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INTRODUCTION
Obstructive sleep apnea syndrome (OSAS) 
is a common disorder, which is characterized 
by instability of the upper airway during sleep, 
resulting in reduction or elimination of airflow, 
oxygen desaturation, and sleep disruption [1]. 
Approximately 4% of middle aged men and 2% 
of middle aged females are estimated to be affect-
ed [1]. OSAS is associated with cardiovascular and 
cerebrovascular disorders and metabolic dysfunc-
tion [2, 3, 4]. 
The association between OSAS and urologic symp-
toms such as nocturia, erectile dysfunction, and 
urgency has been described [5–16]. Sleep disorders 
may present with nocturia [17]. The mechanism 
of nocturia in patients with OSAS is related to partial 
or full obstruction of the airway. An occluded airway 
leads to a rise in the negative intrathoracic pressures 
and increased venous blood flow to the heart. Atrial 
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Introduction To evaluate the impact of continuous positive airway pressure (CPAP) therapy on overactive 
bladder (OAB) symptoms in women with obstructive sleep apnea syndrome (OSAS).
Material and methods One-hundred and fifty women underwent an overnight polysomnography study 
between May 2014 and September 2014. Their voiding symptoms were evaluated using the OAB symp-
tom score (OABSS) and International Consultation on Incontinence Questionnaire Short-Form at OSAS 
diagnosis and approximately 3-months after CPAP therapy. OSAS severity was assessed according to the 
apnea-hypopnea-index.
Results We evaluated 140 women and 111 of them (79.3%) reported symptoms consistent with OAB. 
There were no statistically significant differences between OSAS severity with a prevalence of OAB  
(p = 0.92). The prevalence of urinary incontinence (UI) was 35.7% (n = 50) and 39.6% (n = 44) in all pa-
tients and patients with OAB, respectively. There were no statistically significant differences between  
UI with OAB (p = 0.58). Baseline OABSS is comparable between OSAS severity (p = 0.143). After 
3-months CPAP therapy, OABSS and ICIQ-SF sum scores were significantly decreased in patients with 
severe and moderate OSAS (p <0.01), however, change of OABSS sum score was insignificant in patients 
with mild OSAS (p = 0.44).
Conclusions CPAP therapy improves the OAB, OABSS and ICIQ-SF scores in women with severe and mod-
erate OSAS. OSAS-induced OAB may be alleviated following CPAP therapy.
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natriuretic peptide (ANP) is secreted by the cardiac 
ventricles and right atrium in response to volume 
expansion and an increased pressure load [18]. ANP 
increases sodium and water excretion, inhibits va-
sopressin release and inhibits the renin-angiotensi 
n-aldosterone complex. Thus, nocturia derives from 
nocturnal overproduction of urine in patients with 
OSAS. Treatment of OSAS with continuous positive 
airway pressure (CPAP) prevents nocturia arising 
from OSAS [10].
Overactive bladder (OAB) is another syndrome char-
acterized by urgency, with or without urgency in-
continence, frequency and nocturia in the absence 
of other pathologic features [19]. In Europe, the 
prevalence of OAB is 4–15% in men and 14–40% 
in women [20]. The quality of life of sleep and vital-
ity were compromised in 37% of patients with OAB 
symptoms [21]. There is no previous study, which has 
investigated the relationship between CPAP therapy 
and OAB symptoms. In this study, we evaluated the 
impact of nasal CPAP therapy on OAB symptoms 
in women with OSAS.
MATERIAL AND METHODS
We prospectively evaluated all female patients with 
symptoms of OSAS who underwent an overnight 
polysomnography study between May 2014 and Sep-
tember 2014. We excluded women with diabetes mel-
litus, neurologic disorders (e.g., diabetes insipidus, 
multiple sclerosis, disk herniation, stroke, demen-
tia), congestive heart failure, chronic renal failure, 
physical disabilities, urinary retention, and patients 
who were taking hypnotics, diuretics or anticholin-
ergics. The study protocol was approved by the local 
ethics committee. Informed consent was obtained 
from all participants.
OSAS was diagnosed with an overnight polysomnog-
raphy study. Heart rate, central and occipital elec-
troencephalogram, electromyography, blood oxygen 
saturation, extraocular eye movement, respiratory 
muscle effort, and nasal airflow by thermistor were 
recorded. Apnea was defined as a complete cessation 
of airflow lasting more than 10 seconds. Hypopnea 
was defined as a flow reduction in combination with 
an oxygen desaturation of more than 4% or an arous-
al in the electroencephalogram. The apnea hypopnea 
index (AHI) was the sum of the number of apneas 
and hypopneas per hour of sleep. OSAS was defined 
as an AHI of 5 events per hour and the presence 
of clinical symptoms or AHI of 15 events per hour 
without any OSAS symptoms [22]. The severity 
of OSAS was defined by the AHI. A frequency of 5 
to 15 events per hour, 15 to 30 events per hour and 
more than 30 events per hour was considered mild, 
moderate and severe OSAS, respectively. Minimum 
oxygen saturation and oxygen desaturation indexes 
were also determined.
All patients were asked to answer the overactive blad-
der symptom score (OABSS) and the International 
Consultation on Incontinence Questionnaire Short-
Form (ICIQ-SF) [23, 24]. Validated Turkish transla-
tions of these were used [25, 26]. Patients completed 
self-report questionnaires at two time points: (1) the 
baseline assessment, after OSAS diagnosis; (2) ap-
proximately 3-months after CPAP therapy, patients 
were contacted by phone. 
The OABSS is an 8-item questionnaire for the as-
sessment of OAB including symptoms of daytime fre-
quency, nighttime frequency, urgency and urgency 
incontinence. The possible range of the score sum 
is between 0-40 points. OAB was defined as ≥4 points 
on the OABSS. 
The ICIQ-SF is a 4-item questionnaire for the as-
sessment of urinary continence including the fre-
quency of urinary incontinence (UI), perceived 
amount of urine incontinence and impact on qual-
ity of life (QoL). The possible range of the score sum 
is between 0–21 points. The fourth question asks 
patients to indicate when urine leaks (never, urge 
incontinence, stress incontinence, nocturnal incon-
tinence, physically active/exercising incontinence, 
post-void dribbling, no awareness of urine loss).
Statistical analyses were performed with SPSS ver-
sion 19.0 for Windows (IBM, NY, USA). Numerical 
variables were summarized with mean ± standard 
deviation and categorical variables with frequen-
cy and percentage. The significance of differences 
among groups was assessed by Student’s t test or 
two-way ANOVA, and analysis of categorical vari-
ables was examined by the chi-square test. Correla-
tions between independent variables were assessed 
by Spearman’s correlation test. A p <0.05 was con-
sidered statistical significance.
RESULTS
One-hundred and fifty patients were screened; 
10 patients were excluded, 6 with diabetes mellitus, 
2 taking diuretics, 1 with congestive heart failure 
and 1 with neurologic disorders. The return rate 
of questionnaires was 100%. The mean age, body 
mass index, minimum oxygen saturation, oxygen 
desaturation index, AHI, OABSS and ICIQ-SF pa-
rameters for all patients are shown in Table 1. Se-
vere OSAS was determined in 67 of the 140 patients 
(47.9%), mild and moderate were in 42 (30.0%) and 
31 (22.1%) of the 140 patients, respectively. There 
were no significant differences between OSAS sever-
ity with respect to age and BMI.
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Overall, 111 of the 140 patients (79.3%) reported 
symptoms consistent with OAB, which was defined 
as ≥4 points on the OABSS. There were no statisti-
cally significant differences between OSAS severity 
with a prevalence of OAB (p = 0.92). After 3 months 
of regular CPAP therapy, the overall prevalence 
of OAB decreased to 105 of the 140 patients (75.0%), 
which was statistically insignificant; however the 
prevalence of OAB in severe and moderate OSAS 
groups decreased from 78 of the 98 patients (79.6%) 
to 72 (73.5%), which was statistically significant 
(p = 0.03) (Table 2).
OABSS and ICIQ-SF sum scores at baseline and 
after CPAP therapy are shown in Table 2. Base-
line OABSS is comparable between OSAS severity 
(p = 0.143). After 3 months CPAP therapy, OABSS 
and ICIQ-SF sum scores were significantly de-
creased in patients with severe and moderate OSAS 
(p <0.01), however, change of OABSS sum score was 
insignificant in patients with mild OSAS (p = 0.44). 
The AHI did not correlate with OABSS sum score 
(R =-0.062, p = 0.46). The prevalence of UI was 
35.7% (n = 50) and 39.6% (n = 44) in all patients 
and patients with OAB, respectively. There were no 
statistically significant differences between UI with 
OAB (p = 0.58). Subgroup analysis of the ICIQ-SF 
with type of urine leaks revealed no significant dif-
ferences in OSAS severity. There were no signifi-
cant differences between UI with CPAP therapy 
(p = 0.81).
DISCUSSION
In this study, it was demonstrated that CPAP ther-
apy improves the OAB, OABSS and ICIQ-SF scores 
in women with severe and moderate OSAS. How-
ever, we could not confirm improvement in OAB 
and OABSS score in mild OSAS. We found that the 
prevalence of OAB is high among women with OSAS. 
Our data demonstrates that OSAS severity and AHI 
did not associate with OAB and OABSS sum score in 
women. These findings suggest that CPAP therapy 
for OSAS can provide alleviation of OAB, frequency 
of UI, perceived amount of urine incontinence and 
increment of QoL in women with OSAS.
CPAP therapy improves hypoxia, increases plasma 
NO concentration, and decreases blood pressure 
and sympathetic over activation [11]. It has been 
reported that CPAP therapy significantly improves 
Table 1. Patient characteristics
Variables Mean ± SD (range)
Age (years) 49.3 ±9.6 (22-74)
Body mass index (kg/m2) 29.1 ±4.2 (20-44)
Minimum oxygen saturation (%) 78.0 ±11.1 (40-95)
Oxygen desaturation index 33.0 ±25.0 (116.4-0.9) 
AHI 33.5 ±24.7 (5.0-110.3)
OABSS score 9.6 ±7.2 (0-40)
ICIQ-SF score 2.1 ±3.6 (0-14)
Table 2. Comparative data of patients before and after CPAP therapy
Baseline After CPAP therapy p value
Overall (n=140)
Prevalence of OAB (No. of patients) 
Mean OABSS score  
Mean ICIQ-SF score
111 (79.3%)
9.64 ±7.2
2.10 ±3.6
105 (75.0%)
7.93 ±6.0
1.54 ±3.0
0.31
<0.01
<0.01
Mild OSAS (n=42)
Prevalence of OAB (No. of patients) 
Mean OABSS score
Mean ICIQ-SF score
33 (78.6%)
11.02 ±7.6
3.52 ±4.7
33 (78.6%)
10.88 ±7.5
3.29 ±4.5
1.0
0.44
0.04
Moderate OSAS (n=31)
Prevalence of OAB (No. of patients) 
Mean OABSS score
Mean ICIQ-SF score
24 (77.4%)
7.90 ±5.9
1.90 ±2.9
22 (71.0%)
6.26 ±4.5
1.00 ±1.6
0.5
<0.01
<0.01
Severe OSAS (n=67)
Prevalence of OAB (No. of patients) 
Mean OABSS score
Mean ICIQ-SF score
54 (80.6%)
9.58 ±7.5
1.30 ±2.8
50 (74.6%)
6.85 ±4.9
0.70 ±1.5
0.12
<0.01
<0.01
Severe & moderate OSAS (n=98)
Prevalence of OAB (No. of patients) 
Mean OABSS score
Mean ICIQ-SF score
78 (79.6%)
9.05 ±7.0
1.49 ±2.8
72 (73.5%)
6.66 ±4.8
0.80 ±1.5
0.03
<0.01
<0.01
AHI – apnea hypopnea index; OABSS – overactive bladder symptom score;  
ICIQ-SF – International Consultation on Incontinence Questionnaire Short-Form
OSAS – obstructive sleep apnea symdrome; OABSS – overactive bladder symptom score; ICIQ-SF – International Consultation on Incontinence Questionnaire Short-Form
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in diabetes or stroke has been reported [28]. Thus, 
the mechanism of OSAS induced OAB may be re-
lated to hypoxia as well [16, 28]. Another possible 
mechanism is that malfunction within the central 
nervous system leads to dysregulation of sleep and 
micturition [16]. The hypothalamus regulates sleep, 
arousal and pontine micturition center. The contin-
uous activation of the hypothalamus might induce 
urgency and might fail in the regulation of sleep and 
arousal [16].
One of the limitations of this study is that although 
the analysis was conducted on a sufficient and large 
population, the study population was not based 
on a power calculation. Another limitation is that 
there was no control group or other alternate ther-
apy group such as surgery or mandibular advance-
ment device. The third limitation is the absence 
of information about daytime and nighttime fluid 
intake and urine volumes. Finally, it should be not-
ed that further urodynamic studies will be needed 
to underline our results. To our knowledge, this is 
the first study with the relationship between OAB 
and CPAP therapy in women with OSAS.
CONCLUSIONS
This study shows that CPAP therapy improves 
the OAB, OABSS and ICIQ-SF scores in women with 
severe and moderate OSAS. These findings have 
clinical implications, as OSAS-induced OAB may be 
alleviated following CPAP therapy or women with 
refractory OAB may be diagnosed with untreated 
OSAS. We should consider referral of women with 
refractory OAB to a sleep specialist. Future studies 
about the relationship of OSAS and OAB should fo-
cus on the mechanism of OAB in these patients.
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the problems of OSAS and that patients with se-
vere OSAS may benefit more from therapy [12]. 
This observation might explain why CPAP therapy 
improved OAB in women with severe and moderate 
OSAS. Patients with OSAS show improved erectile 
function with CPAP therapy [12, 15]. Another study 
shows that patients with OSAS and nocturia who are 
treated with CPAP therapy demonstrate a decrease 
in the frequency of nocturia episodes [16]. There 
were no published studies with the relationship be-
tween OAB and CPAP therapy in women with OSAS. 
Epidemiologic surveys of OAB and UI have yielded 
varying prevalence estimates. In Europe, the preva-
lence of OAB is 4–15% in men and 14–40% in wom-
en [20]. Prevalence of UI is 1.6–24% in men and 
4.5–53% in women [27]. The overall prevalence 
of OAB in patients with OSAS is 39% in men and 
no data has been published for women before this 
study [28]. Further, it is shown that the OABSS 
is significantly higher in men with severe and mod-
erate OSAS, compared in men with mild OSAS [28]. 
Our study shows that the OABSS is comparable 
between OSAS severity in women. Another study 
shows that OSAS is detected in 13 out of 16 women 
(81%) with OAB, compared with 4 out of 10 healthy 
women (40%) [29]. OABSS also comprises queries 
about nighttime frequency; therefore our findings 
may not be uniquely related to OAB.
The mechanism between OAB symptoms and 
OSAS is still unclear and may be different in men 
and women. OSAS is often seen in obese patients, 
and the risk of OAB is high in these patients 
[12, 30]. Obesity leads to OAB by way of nerve dys-
function induced by decreased blood flow to the 
bladder; and OSAS induced hypoxia might increase 
this mechanism [16, 31]. Another theory based 
on this phenomenon is that OSAS causes erectile 
dysfunction by hypoxia-induced occult nerve dys-
function [28]. OAB induced by nerve destruction 
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